Post-operative high sensitivity troponin T (hsTnT): toward an extending use for diagnosis and management of myocardial injury after noncardiac surgery?
“…[1] Myocardial injury after non-cardiac surgery (MINS) is a silent event that occurs within 30 days after non-cardiac surgery. [13,14] It is thought to be a stress-induced ischaemia resulting from a myocardial oxygen supply and demand mismatch. [15,16] Unfortunately up to 80% of these MIs are underdiagnosed, [17,18] as the classic symptoms such as chest pain may be atypical or even absent.…”
Section: Researchmentioning
confidence: 99%
“…A therapeutic decision based on hs-cTnT needs to be considered carefully, as therapy could be harmful and increase the risk of bleeding. [14] The MANAGE study evaluated the impact of anticoagulation on perioperative vascular complications after MINS, and provisional results indicate improved outcomes. [48] The POISE study ascertained that beta-blockers were useful in haemodynamically stable patients, but did not rule out the risk of stroke, hypotension, bradycardia and death.…”
“…[1] Myocardial injury after non-cardiac surgery (MINS) is a silent event that occurs within 30 days after non-cardiac surgery. [13,14] It is thought to be a stress-induced ischaemia resulting from a myocardial oxygen supply and demand mismatch. [15,16] Unfortunately up to 80% of these MIs are underdiagnosed, [17,18] as the classic symptoms such as chest pain may be atypical or even absent.…”
Section: Researchmentioning
confidence: 99%
“…A therapeutic decision based on hs-cTnT needs to be considered carefully, as therapy could be harmful and increase the risk of bleeding. [14] The MANAGE study evaluated the impact of anticoagulation on perioperative vascular complications after MINS, and provisional results indicate improved outcomes. [48] The POISE study ascertained that beta-blockers were useful in haemodynamically stable patients, but did not rule out the risk of stroke, hypotension, bradycardia and death.…”
Background
Perioperative myocardial injury is common after major noncardiac surgery and is associated with adverse outcomes. This study investigated the use of ivabradine in patients undergoing urgent surgery for fracture.
Methods and Results
This was a prospective, double‐blind, placebo‐controlled, randomized clinical trial. Participants were enrolled 1:1 into ivabradine or placebo arm, and study drug was commenced before operation and continued for 7 days or until discharge. High‐sensitivity troponin I was measured daily using Abbott Alinity analyzer and assay, and heart rate data were obtained using continuous Holter monitoring. A total of 199 patients underwent acute orthopedic surgery, 98 in the ivabradine group and 101 in the placebo group. The mean age was 78.7 years (range, 77.5–79.9 years), with 68% women. The average heart rate was 5 to 11 beats per minute lower in the ivabradine group compared with the placebo group at all time points (
P
<0.001 for all). There was no statistically significant difference between the ivabradine and placebo groups in the number of patients who had perioperative myocardial injury: 28.6% versus 31.6% (
P
=0.71). In patients with perioperative myocardial injury, average peak troponin was 168.8 ng/L (±431.2 ng/L) in the ivabradine group and 2094.5 ng/L (±7201.9 ng/L) in the placebo group (
P
=0.16). There was no statistically significant difference between groups in 30‐day mortality, blood pressure, stroke, or major adverse cardiovascular event.
Conclusions
Starting ivabradine preoperatively in elderly patients requiring acute surgery for fracture did not result in a statistically significant difference in the incidence of perioperative myocardial injury. There was no statistically significant difference in morbidity, mortality, or adverse events between treatment groups.
Registration
URL:
https://www.anzctr.org.au/
; Unique identifier: ACTRN12616001634460p.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.